{"id":548,"date":"2020-02-21T08:18:20","date_gmt":"2020-02-21T07:18:20","guid":{"rendered":"http:\/\/www.fipwarriors.eu\/?page_id=548"},"modified":"2022-10-30T01:57:25","modified_gmt":"2022-10-29T23:57:25","slug":"gs441524","status":"publish","type":"page","link":"https:\/\/www.fipwarriors.eu\/en\/gs441524\/","title":{"rendered":"GS-441524"},"content":{"rendered":"<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile is-vertically-aligned-top\" style=\"grid-template-columns:auto 31%\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"338\" height=\"480\" src=\"http:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/CID_44468216_500_cropped.gif\" alt=\"\" class=\"wp-image-801 size-full\"\/><\/figure><div class=\"wp-block-media-text__content\">\n<ul class=\"wp-block-list\"><li>Molekulov&yacute; vzorec:   C<sub>12<\/sub>H<sub>13<\/sub>N<sub>5<\/sub>O<sub>4<\/sub> <\/li><li><a class=\"glossaryLink\" aria-describedby=\"tt\" data-cmtooltip=\"&lt;div class=glossaryItemBody&gt;&amp;lt;b&amp;gt;Registra&#269;n&eacute; &#269;&iacute;slo CAS&amp;lt;\/b&amp;gt;&amp;amp;nbsp;je jednozna&#269;n&yacute; numerick&yacute; identifik&aacute;tor, pou&#382;&iacute;van&yacute; v ch&eacute;mii pre chemick&eacute; l&aacute;tky,&amp;amp;nbsp;polym&eacute;ry, biologick&eacute; sekvencie,&amp;amp;nbsp;zmesi&amp;amp;nbsp;a zliatiny. Bolo zaveden&eacute; redakciou svetovo najroz&scaron;&iacute;renej&scaron;ieho chemick&eacute;ho refer&aacute;tov&eacute;ho &#269;asopisu&amp;amp;nbsp;&amp;lt;i&amp;gt;Chemical Abstracts&amp;lt;\/i&amp;gt;, vyd&aacute;van&eacute;ho Americkou chemickou spolo&#269;nos&#357;ou (&amp;lt;i&amp;gt;American Chemical Society&amp;lt;\/i&amp;gt;).&amp;amp;nbsp;&amp;lt;i&amp;gt;Chemical Abtracts Service&amp;lt;\/i&amp;gt;&amp;amp;nbsp;udr&#382;uje datab&aacute;zu chemick&yacute;ch zl&uacute;&#269;en&iacute;n pop&iacute;san&yacute;ch vo vedeckej literat&uacute;re, v patentoch a v in&yacute;ch publik&aacute;ciach (tzv.&amp;amp;nbsp;&amp;lt;i&amp;gt;CAS registry&amp;lt;\/i&amp;gt;). V s&uacute;&#269;asnej dobe t&aacute;to datab&aacute;za obsahuje pribli&#382;ne 23 mili&oacute;nov zl&uacute;&#269;en&iacute;n a denne ich prib&uacute;da v priemere 4-tis&iacute;c. Datab&aacute;za je tie&#382; najautoritat&iacute;vnej&scaron;&iacute;m zdrojom inform&aacute;cii o anglick&yacute;ch n&aacute;zvoch zl&uacute;&#269;en&iacute;n. Preto prakticky v&scaron;etky &scaron;pecializovan&eacute; chemick&eacute; datab&aacute;zy pri identifik&aacute;cii zl&uacute;&#269;en&iacute;n pou&#382;&iacute;vaj&uacute; toto registra&#269;n&eacute; &#269;&iacute;slo ako jeden z vyh&#318;ad&aacute;vac&iacute;ch prvkov.&#268;&iacute;slo je rozdelen&eacute; poml&#269;kami do troch z&oacute;n, kde prv&aacute; z&oacute;na m&aacute; premenn&yacute; po&#269;et &#269;&iacute;slic, &#271;al&scaron;ia m&aacute; v&#382;dy pr&aacute;ve dve &#269;&iacute;slice a posledn&aacute; z&oacute;na obsahuje jedin&uacute; &#269;&iacute;slicu, ktor&aacute; sl&uacute;&#382;i ako kontroln&yacute; s&uacute;&#269;et pre umo&#382;nenie automatickej kontroly spr&aacute;vnosti z&aacute;pisu registra&#269;n&eacute;ho &#269;&iacute;sla&lt;\/div&gt;\" href=\"https:\/\/www.fipwarriors.eu\/en\/glossary\/cas\/\" data-mobile-support=\"0\" data-gt-translate-attributes='[{\"attribute\":\"data-cmtooltip\", \"format\":\"html\"}]' tabindex=\"0\" role=\"link\">CAS<\/a>#  1191237-69-0 <\/li><li><a class=\"glossaryLink\" aria-describedby=\"tt\" data-cmtooltip=\"&lt;div class=glossaryItemBody&gt;&amp;lt;strong&amp;gt;Molekulov&aacute; hmotnos&#357;&amp;lt;\/strong&amp;gt;&nbsp; je s&uacute;&#269;et at&oacute;mov&yacute;ch hmotnost&iacute; at&oacute;mov danej molekuly.&lt;\/div&gt;\" href=\"https:\/\/www.fipwarriors.eu\/en\/glossary\/molarna-hmotnost\/\" data-mobile-support=\"0\" data-gt-translate-attributes='[{\"attribute\":\"data-cmtooltip\", \"format\":\"html\"}]' tabindex=\"0\" role=\"link\">Molekulov&aacute; hmotnos&#357;<\/a>:   291.26 <\/li><li> (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile<\/li><li>Pr&aacute;&scaron;ok bielej farby s mierne na&#382;ltl&yacute;m odtie&#328;om<\/li><li>Synonymum &ndash;  EVO984 <\/li><li>Remdesivir metabolite <\/li><li>Patent# <a href=\"https:\/\/patents.google.com\/patent\/WO2009132135A1\/en\" target=\"_blank\" rel=\"noreferrer noopener\">WO2009132135A1<\/a>; <a rel=\"noreferrer noopener\" href=\"http:\/\/appft1.uspto.gov\/netacgi\/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;d=PG01&amp;p=1&amp;u=\/netahtml\/PTO\/srchnum.html&amp;r=1&amp;f=G&amp;l=50&amp;s1=20180296584.PGNR.&amp;OS=DN\/20180296584&amp;RS=DN\/20180296584\" target=\"_blank\">US20180296584<\/a>, (<a rel=\"noreferrer noopener\" href=\"https:\/\/patentimages.storage.googleapis.com\/48\/98\/83\/082c45290748a1\/US20180296584A1.pdf\" target=\"_blank\">US20180296584A1<\/a>)<br>Vlastn&iacute;k: <a rel=\"noreferrer noopener\" href=\"https:\/\/cs.wikipedia.org\/wiki\/Gilead_Sciences\" target=\"_blank\">Gilead Sciences , Inc<\/a>  <\/li><li><a rel=\"noreferrer noopener\" href=\"https:\/\/www.chemsrc.com\/en\/cas\/1191237-69-0_1557822.html\" target=\"_blank\">ChemSrc<\/a>, <a rel=\"noreferrer noopener\" href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/44468216\" target=\"_blank\">PubChem<\/a><\/li><\/ul>\n<\/div><\/div>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"mechanizmus-ucinku\">Mechanizmus &uacute;&#269;inku<\/h3>\n\n\n\n<p class=\"clear-left\">GS-441524 (GS = Gilead Sciences), je <a class=\"glossaryLink\" aria-describedby=\"tt\" data-cmtooltip=\"&lt;div class=glossaryItemBody&gt;&amp;lt;strong&amp;gt;Nukleosidov&eacute; analogy&amp;lt;\/strong&amp;gt; jsou nukleosidy , kter&eacute; obsahuj&iacute; analog nukleov&eacute; kyseliny a cukru. Nukleotidov&eacute; analogy jsou nukleotidy , kter&eacute; obsahuj&iacute; analog nukleov&eacute; kyseliny, cukr, a jeden a&#382; t&#345;i fosf&aacute;tov&eacute; skupiny .Nukleosidov&eacute; a nukleotidov&eacute; analogy mohou b&yacute;t pou&#382;ity u terapeutick&yacute;ch l&eacute;&#269;iv, zahrnuj&iacute; celou &#345;adu antivirov&yacute;ch p&#345;&iacute;pravk&#367; pou&#382;&iacute;van&yacute;ch k zabr&aacute;n&#283;n&iacute; virov&eacute; replikace v infikovan&yacute;ch bu&#328;k&aacute;ch.&lt;\/div&gt;\" href=\"https:\/\/www.fipwarriors.eu\/en\/glossary\/nukleosidovy-analog\/\" data-mobile-support=\"0\" data-gt-translate-attributes='[{\"attribute\":\"data-cmtooltip\", \"format\":\"html\"}]' tabindex=\"0\" role=\"link\">nukleosidov&yacute; anal&oacute;g<\/a> a molekul&aacute;rny <a class=\"glossaryLink\" aria-describedby=\"tt\" data-cmtooltip=\"&lt;div class=glossaryItemBody&gt;&amp;lt;b&amp;gt;Prekurzor&amp;lt;\/b&amp;gt; je v&yacute;chodiskov&aacute; l&aacute;tka, &#269;astica, z ktorej vznik&aacute; chemickou premenou v&yacute;sledn&yacute; produkt.&lt;\/div&gt;\" href=\"https:\/\/www.fipwarriors.eu\/en\/glossary\/prekurzor\/\" data-mobile-support=\"0\" data-gt-translate-attributes='[{\"attribute\":\"data-cmtooltip\", \"format\":\"html\"}]' tabindex=\"0\" role=\"link\">prekurzor<\/a> farmakologicky akt&iacute;vnej nukleosidovej trifosf&aacute;tovej molekuly. GS-441524 sa st&aacute;va akt&iacute;vnym a&#382; po vn&uacute;trobune&#269;nej metaboliz&aacute;cii na trifosf&aacute;t, ktor&yacute; je falo&scaron;n&yacute;m substr&aacute;tom pre v&iacute;rusov&uacute; <a class=\"glossaryLink\" aria-describedby=\"tt\" data-cmtooltip=\"&lt;div class=glossaryItemBody&gt;Ribonukleov&aacute; kyselina. Polymern&iacute; makromolekula, jej&iacute;&#382; z&aacute;kladn&iacute;mi stavebn&iacute;mi jednotkami jsou ribonukleotidy. Je sou&#269;&aacute;st&iacute; v&scaron;ech bun&#283;k a slou&#382;&iacute; k p&#345;enosu informac&iacute; z DNA d&aacute;le do bu&#328;ky. Existuje mnoho druh&#367; RNA s r&#367;zn&yacute;mi funkcemi. Mezi nejzn&aacute;mn&#283;j&scaron;&iacute; pat&#345;&iacute; mRNA (medi&aacute;torov&aacute;), tRNA (transferov&aacute;) a rRNA (ribozom&aacute;ln&iacute;).&lt;\/div&gt;\" href=\"https:\/\/www.fipwarriors.eu\/en\/glossary\/rna\/\" data-mobile-support=\"0\" data-gt-translate-attributes='[{\"attribute\":\"data-cmtooltip\", \"format\":\"html\"}]' tabindex=\"0\" role=\"link\">RNA<\/a> dependentn&uacute; RNA polymer&aacute;zu. Jedn&aacute; sa teda o <a class=\"glossaryLink\" aria-describedby=\"tt\" data-cmtooltip=\"&lt;div class=glossaryItemBody&gt;L&aacute;tka v&yacute;razne spoma&#318;uj&uacute;ca alebo zastavuj&uacute;ca reakciu.&lt;\/div&gt;\" href=\"https:\/\/www.fipwarriors.eu\/en\/glossary\/inhibitor\/\" data-mobile-support=\"0\" data-gt-translate-attributes='[{\"attribute\":\"data-cmtooltip\", \"format\":\"html\"}]' tabindex=\"0\" role=\"link\">inhib&iacute;tor<\/a>, ktor&yacute; p&ocirc;sob&iacute; ako ukon&#269;ovacia sekvencia (termin&aacute;tor) re&#357;azca v&iacute;rusovej RNA a v&iacute;rus sa nem&ocirc;&#382;e &#271;alej replikova&#357;.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"priprava-gs-441524-pre-injekcne-pouzitie\">Pr&iacute;prava GS-441524 pre injek&#269;n&eacute; pou&#382;itie<\/h3>\n\n\n\n<p>Po&#269;as klinick&yacute;ch testov bol GS-441524 rozpusten&yacute; na koncentr&aacute;ciu 10 alebo 15 mg\/ml v roztoku so zlo&#382;en&iacute;m:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>5% etanol<\/li><li>30% propyl&eacute;nglykol<\/li><li>45% PEG 400 (polyetyl&eacute;nglykol)<\/li><li>20% voda s HCL pre nastavenie v&yacute;sledn&eacute;ho pH na hodnotu 1,5<\/li><\/ul>\n\n\n\n<p>V&yacute;sledn&aacute; zmes bola v sterilnej 50ml n&aacute;dobe pretrepan&aacute; do rozpustenia a potom umiestnen&aacute; do ultrazvukovej l&aacute;zne na 5-20 min&uacute;t, k&yacute;m sa stala celkom &#269;&iacute;rou.  Takto rozpusten&yacute; liek bol n&aacute;sledne uskladnen&yacute; v chladni&#269;ke a bol pou&#382;it&yacute; do 3-4 t&yacute;&#382;d&#328;ov.<\/p>\n\n\n\n<p>Vy&scaron;&scaron;ie uveden&eacute; zlo&#382;enie rozp&uacute;&scaron;&#357;adla prevzali aj v&scaron;etci v&yacute;robcovia <a href=\"https:\/\/www.fipwarriors.eu\/lieky\/\">liekov<\/a>, hoci pod&#318;a reakci&iacute; ma&#269;iek na r&ocirc;zne zna&#269;ky liekov je zjavn&eacute;, &#382;e nejak&eacute; rozdiely v pou&#382;itej recept&uacute;re pre rozp&uacute;&scaron;&#357;adlo predsa len existuj&uacute;.  V&auml;&#269;&scaron;ina liekov na trhu sa vyr&aacute;ba v koncentr&aacute;cii 15mg\/ml.<\/p>\n\n\n\n<div class=\"aligncenter wp-block-ugb-button ugb-button-wrapper ugb-154564f ugb-main-block\"><style>.ugb-154564f .ugb-block-content{justify-content:center !important}.ugb-154564f .ugb-button1{background-color:#cf2e2e;border-radius:0px !important}.ugb-154564f .ugb-button1 .ugb-button--inner,.ugb-154564f .ugb-button1 svg:not(.ugb-custom-icon){color:#ffffff !important}.ugb-154564f .ugb-button1:before{border-radius:0px !important}.ugb-154564f .ugb-inner-block{text-align:center}<\/style><div class=\"ugb-inner-block\"><div class=\"ugb-block-content\"><div class=\"ugb-button-container\"><a class=\"ugb-button1 ugb-button ugb-button--size-normal\" href=\"https:\/\/www.fipwarriors.eu\/ucinnost-a-bezpecnost-nukleozidoveho-analogu-gs-441524-pri-liecbe-maciek-s-prirodzene-sa-vyskytujucou-macacou-infekcnou-peritonitidou\/\" rel=\"nofollow\" title=\"\"><span class=\"ugb-button--inner\">KLINICK&Aacute; &Scaron;T&Uacute;DIA<br>&Uacute;&#269;innos&#357; a bezpe&#269;nos&#357; nukleozidov&eacute;ho anal&oacute;gu GS-441524 pri lie&#269;be ma&#269;iek s prirodzene sa vyskytuj&uacute;cou ma&#269;acou infek&#269;nou peritonit&iacute;dou<\/span><\/a><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Molekulov&yacute; vzorec: C12H13N5O4 CAS# 1191237-69-0 Molekulov&aacute; hmotnos&#357;: 291.26 (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile Pr&aacute;&scaron;ok bielej farby s mierne na&#382;ltl&yacute;m odtie&#328;om Synonymum &ndash; EVO984 Remdesivir metabolite Patent# WO2009132135A1; US20180296584, (US20180296584A1)Vlastn&iacute;k: Gilead Sciences , Inc ChemSrc, PubChem Mechanizmus &uacute;&#269;inku GS-441524 (GS = Gilead Sciences), je nukleosidov&yacute; anal&oacute;g a molekul&aacute;rny prekurzor farmakologicky akt&iacute;vnej nukleosidovej trifosf&aacute;tovej molekuly. GS-441524 sa st&aacute;va akt&iacute;vnym a&#382; po &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.fipwarriors.eu\/en\/gs441524\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &quot;GS-441524&quot;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":854,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_uag_custom_page_level_css":"","footnotes":""},"categories":[],"tags":[],"class_list":["post-548","page","type-page","status-publish","has-post-thumbnail","hentry"],"featured_image_urls_v2":{"full":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg",1920,650,false],"thumbnail":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-150x150.jpg",150,150,true],"medium":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-300x102.jpg",300,102,true],"medium_large":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-768x260.jpg",525,178,true],"large":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-1024x347.jpg",525,178,true],"1536x1536":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-1536x520.jpg",1536,520,true],"2048x2048":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg",1920,650,false],"trp-custom-language-flag":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg",18,6,false],"twentyseventeen-featured-image":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg",1920,650,false],"twentyseventeen-thumbnail-avatar":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-100x100.jpg",100,100,true],"woocommerce_thumbnail":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-250x250.jpg",250,250,true],"woocommerce_single":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-350x118.jpg",350,118,true],"woocommerce_gallery_thumbnail":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-100x100.jpg",100,100,true]},"post_excerpt_stackable_v2":"<p>Molekulov&yacute; vzorec: C12H13N5O4 <a class=\"glossaryLink\" aria-describedby=\"tt\" data-cmtooltip=\"&lt;div class=glossaryItemBody&gt;&amp;lt;b&amp;gt;Registra&#269;n&eacute; &#269;&iacute;slo CAS&amp;lt;\/b&amp;gt;&amp;amp;nbsp;je jednozna&#269;n&yacute; numerick&yacute; identifik&aacute;tor, pou&#382;&iacute;van&yacute; v ch&eacute;mii pre chemick&eacute; l&aacute;tky,&amp;amp;nbsp;polym&eacute;ry, biologick&eacute; sekvencie,&amp;amp;nbsp;zmesi&amp;amp;nbsp;a zliatiny. Bolo zaveden&eacute; redakciou svetovo najroz&scaron;&iacute;renej&scaron;ieho chemick&eacute;ho refer&aacute;tov&eacute;ho &#269;asopisu&amp;amp;nbsp;&amp;lt;i&amp;gt;Chemical Abstracts&amp;lt;\/i&amp;gt;, vyd&aacute;van&eacute;ho Americkou chemickou spolo&#269;nos&#357;ou (&amp;lt;i&amp;gt;American Chemical Society&amp;lt;\/i&amp;gt;).&amp;amp;nbsp;&amp;lt;i&amp;gt;Chemical Abtracts Service&amp;lt;\/i&amp;gt;&amp;amp;nbsp;udr&#382;uje datab&aacute;zu chemick&yacute;ch zl&uacute;&#269;en&iacute;n pop&iacute;san&yacute;ch vo vedeckej literat&uacute;re, v patentoch a v in&yacute;ch publik&aacute;ciach (tzv.&amp;amp;nbsp;&amp;lt;i&amp;gt;CAS registry&amp;lt;\/i&amp;gt;). V s&uacute;&#269;asnej dobe t&aacute;to datab&aacute;za obsahuje pribli&#382;ne 23 mili&oacute;nov zl&uacute;&#269;en&iacute;n a denne ich prib&uacute;da v priemere 4-tis&iacute;c. Datab&aacute;za je tie&#382; najautoritat&iacute;vnej&scaron;&iacute;m zdrojom inform&aacute;cii o anglick&yacute;ch n&aacute;zvoch zl&uacute;&#269;en&iacute;n. Preto prakticky v&scaron;etky &scaron;pecializovan&eacute; chemick&eacute; datab&aacute;zy pri identifik&aacute;cii zl&uacute;&#269;en&iacute;n pou&#382;&iacute;vaj&uacute; toto registra&#269;n&eacute; &#269;&iacute;slo ako jeden z vyh&#318;ad&aacute;vac&iacute;ch prvkov.&#268;&iacute;slo je rozdelen&eacute; poml&#269;kami do troch z&oacute;n, kde prv&aacute; z&oacute;na m&aacute; premenn&yacute; po&#269;et &#269;&iacute;slic, &#271;al&scaron;ia m&aacute; v&#382;dy pr&aacute;ve dve &#269;&iacute;slice a posledn&aacute; z&oacute;na obsahuje jedin&uacute; &#269;&iacute;slicu, ktor&aacute; sl&uacute;&#382;i ako kontroln&yacute; s&uacute;&#269;et pre umo&#382;nenie automatickej kontroly spr&aacute;vnosti z&aacute;pisu registra&#269;n&eacute;ho &#269;&iacute;sla&lt;\/div&gt;\" href=\"https:\/\/www.fipwarriors.eu\/en\/glossary\/cas\/\" data-mobile-support=\"0\" data-gt-translate-attributes='[{\"attribute\":\"data-cmtooltip\", \"format\":\"html\"}]' tabindex=\"0\" role=\"link\">CAS<\/a># 1191237-69-0 <a class=\"glossaryLink\" aria-describedby=\"tt\" data-cmtooltip=\"&lt;div class=glossaryItemBody&gt;&amp;lt;strong&amp;gt;Molekulov&aacute; hmotnos&#357;&amp;lt;\/strong&amp;gt;&nbsp; je s&uacute;&#269;et at&oacute;mov&yacute;ch hmotnost&iacute; at&oacute;mov danej molekuly.&lt;\/div&gt;\" href=\"https:\/\/www.fipwarriors.eu\/en\/glossary\/molarna-hmotnost\/\" data-mobile-support=\"0\" data-gt-translate-attributes='[{\"attribute\":\"data-cmtooltip\", \"format\":\"html\"}]' tabindex=\"0\" role=\"link\">Molekulov&aacute; hmotnos&#357;<\/a>: 291.26 (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrilePr&aacute;&scaron;ok bielej farby s mierne na&#382;ltl&yacute;m odtie&#328;omSynonymum &ndash; EVO984 Remdesivir metabolite Patent# WO2009132135A1; US20180296584, (US20180296584A1)Vlastn&iacute;k: Gilead Sciences , Inc ChemSrc, PubChem Mechanizmus &uacute;&#269;inku GS-441524 (GS = Gilead Sciences), je <a class=\"glossaryLink\" aria-describedby=\"tt\" data-cmtooltip=\"&lt;div class=glossaryItemBody&gt;&amp;lt;strong&amp;gt;Nukleosidov&eacute; analogy&amp;lt;\/strong&amp;gt; jsou nukleosidy , kter&eacute; obsahuj&iacute; analog nukleov&eacute; kyseliny a cukru. Nukleotidov&eacute; analogy jsou nukleotidy , kter&eacute; obsahuj&iacute; analog nukleov&eacute; kyseliny, cukr, a jeden a&#382; t&#345;i fosf&aacute;tov&eacute; skupiny .Nukleosidov&eacute; a nukleotidov&eacute; analogy mohou b&yacute;t pou&#382;ity u terapeutick&yacute;ch l&eacute;&#269;iv, zahrnuj&iacute; celou &#345;adu antivirov&yacute;ch p&#345;&iacute;pravk&#367; pou&#382;&iacute;van&yacute;ch k zabr&aacute;n&#283;n&iacute; virov&eacute; replikace v infikovan&yacute;ch bu&#328;k&aacute;ch.&lt;\/div&gt;\" href=\"https:\/\/www.fipwarriors.eu\/en\/glossary\/nukleosidovy-analog\/\" data-mobile-support=\"0\" data-gt-translate-attributes='[{\"attribute\":\"data-cmtooltip\", \"format\":\"html\"}]' tabindex=\"0\" role=\"link\">nukleosidov&yacute; anal&oacute;g<\/a> a molekul&aacute;rny <a class=\"glossaryLink\" aria-describedby=\"tt\" data-cmtooltip=\"&lt;div class=glossaryItemBody&gt;&amp;lt;b&amp;gt;Prekurzor&amp;lt;\/b&amp;gt; je v&yacute;chodiskov&aacute; l&aacute;tka, &#269;astica, z ktorej vznik&aacute; chemickou premenou v&yacute;sledn&yacute; produkt.&lt;\/div&gt;\" href=\"https:\/\/www.fipwarriors.eu\/en\/glossary\/prekurzor\/\" data-mobile-support=\"0\" data-gt-translate-attributes='[{\"attribute\":\"data-cmtooltip\", \"format\":\"html\"}]' tabindex=\"0\" role=\"link\">prekurzor<\/a> farmakologicky akt&iacute;vnej nukleosidovej trifosf&aacute;tovej molekuly. GS-441524 sa st&aacute;va akt&iacute;vnym a&#382; po vn&uacute;trobune&#269;nej metaboliz&aacute;cii na trifosf&aacute;t, ktor&yacute; je falo&scaron;n&yacute;m substr&aacute;tom pre v&iacute;rusov&uacute; RNA dependentn&uacute; RNA polymer&aacute;zu. Jedn&aacute; sa teda o inhib&iacute;tor, ktor&yacute; p&ocirc;sob&iacute; ako ukon&#269;ovacia sekvencia (termin&aacute;tor) re&#357;azca v&iacute;rusovej RNA a v&iacute;rus sa nem&ocirc;&#382;e &#271;alej replikova&#357;. Pr&iacute;prava GS-441524 pre injek&#269;n&eacute; pou&#382;itie Po&#269;as klinick&yacute;ch testov bol GS-441524 rozpusten&yacute; na koncentr&aacute;ciu&hellip;<\/p>\n","category_list_v2":"Uncategorised","author_info_v2":{"name":"LM","url":"https:\/\/www.fipwarriors.eu\/en\/author\/starman\/"},"comments_num_v2":"0 comments","featured_image_src":"https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg","yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GS-441524 - FIP Warriors CZ\/SK \u00ae<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fipwarriors.eu\/en\/gs441524\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GS-441524 - FIP Warriors CZ\/SK \u00ae\" \/>\n<meta property=\"og:description\" content=\"Molekulov&yacute; vzorec: C12H13N5O4 CAS# 1191237-69-0 Molekulov&aacute; hmotnos&#357;: 291.26 (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile Pr&aacute;&scaron;ok bielej farby s mierne na&#382;ltl&yacute;m odtie&#328;om Synonymum &ndash; EVO984 Remdesivir metabolite Patent# WO2009132135A1; US20180296584, (US20180296584A1)Vlastn&iacute;k: Gilead Sciences , Inc ChemSrc, PubChem Mechanizmus &uacute;&#269;inku GS-441524 (GS = Gilead Sciences), je nukleosidov&yacute; anal&oacute;g a molekul&aacute;rny prekurzor farmakologicky akt&iacute;vnej nukleosidovej trifosf&aacute;tovej molekuly. GS-441524 sa st&aacute;va akt&iacute;vnym a&#382; po &hellip; Continue reading &quot;GS-441524&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fipwarriors.eu\/en\/gs441524\/\" \/>\n<meta property=\"og:site_name\" content=\"FIP Warriors CZ\/SK \u00ae\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/groups\/fipczsk\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-29T23:57:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"650\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fipwarriors.eu\/gs441524\/\",\"url\":\"https:\/\/www.fipwarriors.eu\/gs441524\/\",\"name\":\"GS-441524 - FIP Warriors CZ\/SK \u00ae\",\"isPartOf\":{\"@id\":\"https:\/\/www.fipwarriors.eu\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fipwarriors.eu\/gs441524\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fipwarriors.eu\/gs441524\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg\",\"datePublished\":\"2020-02-21T07:18:20+00:00\",\"dateModified\":\"2022-10-29T23:57:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fipwarriors.eu\/gs441524\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fipwarriors.eu\/gs441524\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.fipwarriors.eu\/gs441524\/#primaryimage\",\"url\":\"https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg\",\"contentUrl\":\"https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg\",\"width\":1920,\"height\":650},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fipwarriors.eu\/gs441524\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Domovsk\u00e1 str\u00e1nka\",\"item\":\"https:\/\/www.fipwarriors.eu\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GS-441524\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fipwarriors.eu\/#website\",\"url\":\"https:\/\/www.fipwarriors.eu\/\",\"name\":\"FIP Warriors CZ\/SK \u00ae\",\"description\":\"Pre v\u0161etk\u00fdch FIP bojovn\u00edkov\",\"publisher\":{\"@id\":\"https:\/\/www.fipwarriors.eu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fipwarriors.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fipwarriors.eu\/#organization\",\"name\":\"FIP Warriors CZ\/SK \u00ae\",\"url\":\"https:\/\/www.fipwarriors.eu\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.fipwarriors.eu\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2021\/12\/cropped-fip-warriors-logo.png\",\"contentUrl\":\"https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2021\/12\/cropped-fip-warriors-logo.png\",\"width\":315,\"height\":315,\"caption\":\"FIP Warriors CZ\/SK \u00ae\"},\"image\":{\"@id\":\"https:\/\/www.fipwarriors.eu\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/groups\/fipczsk\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GS-441524 - FIP Warriors CZ\/SK \u00ae","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fipwarriors.eu\/en\/gs441524\/","og_locale":"en_GB","og_type":"article","og_title":"GS-441524 - FIP Warriors CZ\/SK \u00ae","og_description":"Molekulov&yacute; vzorec: C12H13N5O4 CAS# 1191237-69-0 Molekulov&aacute; hmotnos&#357;: 291.26 (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile Pr&aacute;&scaron;ok bielej farby s mierne na&#382;ltl&yacute;m odtie&#328;om Synonymum &ndash; EVO984 Remdesivir metabolite Patent# WO2009132135A1; US20180296584, (US20180296584A1)Vlastn&iacute;k: Gilead Sciences , Inc ChemSrc, PubChem Mechanizmus &uacute;&#269;inku GS-441524 (GS = Gilead Sciences), je nukleosidov&yacute; anal&oacute;g a molekul&aacute;rny prekurzor farmakologicky akt&iacute;vnej nukleosidovej trifosf&aacute;tovej molekuly. GS-441524 sa st&aacute;va akt&iacute;vnym a&#382; po &hellip; Continue reading &quot;GS-441524&quot;","og_url":"https:\/\/www.fipwarriors.eu\/en\/gs441524\/","og_site_name":"FIP Warriors CZ\/SK \u00ae","article_publisher":"https:\/\/www.facebook.com\/groups\/fipczsk","article_modified_time":"2022-10-29T23:57:25+00:00","og_image":[{"width":1920,"height":650,"url":"https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.fipwarriors.eu\/gs441524\/","url":"https:\/\/www.fipwarriors.eu\/gs441524\/","name":"GS-441524 - FIP Warriors CZ\/SK \u00ae","isPartOf":{"@id":"https:\/\/www.fipwarriors.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fipwarriors.eu\/gs441524\/#primaryimage"},"image":{"@id":"https:\/\/www.fipwarriors.eu\/gs441524\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg","datePublished":"2020-02-21T07:18:20+00:00","dateModified":"2022-10-29T23:57:25+00:00","breadcrumb":{"@id":"https:\/\/www.fipwarriors.eu\/gs441524\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fipwarriors.eu\/gs441524\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.fipwarriors.eu\/gs441524\/#primaryimage","url":"https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg","contentUrl":"https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg","width":1920,"height":650},{"@type":"BreadcrumbList","@id":"https:\/\/www.fipwarriors.eu\/gs441524\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Domovsk\u00e1 str\u00e1nka","item":"https:\/\/www.fipwarriors.eu\/"},{"@type":"ListItem","position":2,"name":"GS-441524"}]},{"@type":"WebSite","@id":"https:\/\/www.fipwarriors.eu\/#website","url":"https:\/\/www.fipwarriors.eu\/","name":"FIP Warriors CZ \/ SK \u00ae","description":"For all FIP warriors","publisher":{"@id":"https:\/\/www.fipwarriors.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fipwarriors.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.fipwarriors.eu\/#organization","name":"FIP Warriors CZ \/ SK \u00ae","url":"https:\/\/www.fipwarriors.eu\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.fipwarriors.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2021\/12\/cropped-fip-warriors-logo.png","contentUrl":"https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2021\/12\/cropped-fip-warriors-logo.png","width":315,"height":315,"caption":"FIP Warriors CZ\/SK \u00ae"},"image":{"@id":"https:\/\/www.fipwarriors.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/groups\/fipczsk"]}]}},"uagb_featured_image_src":{"full":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg",1920,650,false],"thumbnail":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-150x150.jpg",150,150,true],"medium":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-300x102.jpg",300,102,true],"medium_large":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-768x260.jpg",525,178,true],"large":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-1024x347.jpg",525,178,true],"1536x1536":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-1536x520.jpg",1536,520,true],"2048x2048":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg",1920,650,false],"trp-custom-language-flag":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg",18,6,false],"twentyseventeen-featured-image":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1.jpg",1920,650,false],"twentyseventeen-thumbnail-avatar":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-100x100.jpg",100,100,true],"woocommerce_thumbnail":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-250x250.jpg",250,250,true],"woocommerce_single":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-350x118.jpg",350,118,true],"woocommerce_gallery_thumbnail":["https:\/\/www.fipwarriors.eu\/wp-content\/uploads\/2020\/02\/catbanner1-100x100.jpg",100,100,true]},"uagb_author_info":{"display_name":"L. M.","author_link":"https:\/\/www.fipwarriors.eu\/en\/author\/starman\/"},"uagb_comment_info":0,"uagb_excerpt":"Molekulov&yacute; vzorec: C12H13N5O4 CAS# 1191237-69-0 Molekulov&aacute; hmotnos&#357;: 291.26 (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile Pr&aacute;&scaron;ok bielej farby s mierne na&#382;ltl&yacute;m odtie&#328;om Synonymum &ndash; EVO984 Remdesivir metabolite Patent# WO2009132135A1; US20180296584, (US20180296584A1)Vlastn&iacute;k: Gilead Sciences , Inc ChemSrc, PubChem Mechanizmus &uacute;&#269;inku GS-441524 (GS = Gilead Sciences), je nukleosidov&yacute; anal&oacute;g a molekul&aacute;rny prekurzor farmakologicky akt&iacute;vnej nukleosidovej trifosf&aacute;tovej molekuly. GS-441524 sa st&aacute;va akt&iacute;vnym a&#382; po&hellip;","_links":{"self":[{"href":"https:\/\/www.fipwarriors.eu\/en\/wp-json\/wp\/v2\/pages\/548","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fipwarriors.eu\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.fipwarriors.eu\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.fipwarriors.eu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fipwarriors.eu\/en\/wp-json\/wp\/v2\/comments?post=548"}],"version-history":[{"count":0,"href":"https:\/\/www.fipwarriors.eu\/en\/wp-json\/wp\/v2\/pages\/548\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fipwarriors.eu\/en\/wp-json\/wp\/v2\/media\/854"}],"wp:attachment":[{"href":"https:\/\/www.fipwarriors.eu\/en\/wp-json\/wp\/v2\/media?parent=548"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fipwarriors.eu\/en\/wp-json\/wp\/v2\/categories?post=548"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fipwarriors.eu\/en\/wp-json\/wp\/v2\/tags?post=548"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}